XML 25 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities      
Net income (loss) $ 4.1 $ 33.7 $ (0.6)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:      
Depreciation and amortization 26.8 25.6 27.9
Provision for credit losses 0.6 1.6 1.2
Provision for warranties 18.6 17.6 12.6
Deferred compensation benefit (0.1) (0.1) (0.9)
Share-based compensation 5.0 4.1 6.8
Deferred tax benefit (6.8) (6.4) (17.1)
Gain on disposition of property and equipment, net (1.1) (3.1) (0.7)
Goodwill impairment 20.2 0.0 0.0
Other impairment charges 0.0 1.2 3.5
Amortization of debt issuance costs 0.3 0.3 0.0
Distributions to deferred compensation programs' participants (1.1) (1.8) (1.0)
Change in operating assets and liabilities, excluding the effects of acquisitions:      
(Purchase) sale of trading securities, net (1.5) (0.3) 0.7
Receivables and other contract assets (20.6) 20.5 (28.0)
Inventories 27.4 (63.0) (96.4)
Prepaid expenses (3.5) 2.2 (2.8)
Other assets (0.9) (12.8) (16.2)
Accounts payable (35.9) 7.7 25.5
Accrued loss reserves (0.9) 1.4 (0.1)
Accrued employee related liabilities (5.4) 8.7 4.3
Other accrued liabilities (2.0) (0.8) 2.6
Accrued product warranty (18.9) (13.1) (11.1)
Customer deposits 7.6 1.0 9.9
Income taxes payable/prepaid 11.1 3.6 6.0
Net cash provided by (used in) operating activities 23.0 27.8 (73.9)
Cash flows from investing activities:      
Acquisitions, net of cash acquired 0.0 0.0 (17.8)
Expenditures for property and equipment (20.5) (34.1) (40.7)
Proceeds from sale of property and equipment 2.3 20.3 5.7
Proceeds from insurance 0.4 0.0 0.0
Purchase of investments (1.1) (1.0) (1.0)
Sale of investments 0.9 1.9 0.6
Net cash used in investing activities (18.0) (12.9) (53.2)
Cash flows from financing activities:      
Payment of dividends (11.9) (11.8) (11.2)
Proceeds from borrowings on credit facilities and bank loans 215.6 240.6 223.0
Repayments of borrowings on credit facilities and bank loans (179.2) (245.8) (138.5)
Payment of debt issuance costs 0.0 0.0 (1.5)
Sale of Company stock by deferred compensation programs, net 0.4 0.3 0.2
Withholding tax paid upon vesting of share-based compensation awards (0.5) (1.6) (1.8)
Repurchase of Company stock 0.0 0.0 (10.1)
Net cash provided by (used in) financing activities 24.4 (18.3) 60.1
Effect of exchange rates on cash (1.8) 0.6 (1.4)
Increase (decrease) in cash and cash equivalents and restricted cash 27.6 (2.8) (68.4)
Cash, cash equivalents and restricted cash, beginning of period 63.2 66.0 134.4
Cash, cash equivalents and restricted cash, end of period 90.8 63.2 66.0
Cash paid during the year for:      
Interest 8.5 7.0 1.1
Income taxes paid, net 8.2 13.8 17.7
Supplemental disclosures of non-cash items      
Capital expenditures in accounts payable 1.0 1.5 1.5
Additions to right-of-use assets and lease liabilities $ 2.4 $ 0.8 $ 7.3